Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis

被引:4
|
作者
Habboush, Shady [1 ]
Sofy, Ahmed Adel [2 ]
Masoud, Ahmed Taher [2 ]
Cherfaoui, Omar [1 ]
Farhat, Abdullah Mohamed [2 ]
Abdelsattar, Ahmed Taha [2 ]
Elmoursi, Ahmed [3 ]
机构
[1] Jordan Univ, Sch Med, Amman, Jordan
[2] Fayoum Univ, Fac Med, Al Fayyum, Egypt
[3] Univ Kentucky, Coll Med, Dept Internal Med, 800 Rose St, Lexington, KY 40508 USA
关键词
Hypertension; Triple antihypertensive therapy; Single-pill therapy; Systematic review; Meta-analysis; BLOOD-PRESSURE; COMBINATION THERAPY; FIXED COMBINATION; PERINDOPRIL; INDAPAMIDE; TRIAL; PREVALENCE; AMLODIPINE; OUTCOMES;
D O I
10.1007/s40292-022-00511-y
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction Systemic arterial hypertension is the most common preventable risk factor for all causes of morbidity and mortality worldwide with a prevalence of 35-40% of the adults. Despite the wide variety of effective antihypertensive medications, most hypertensive patients remain uncontrolled. However, the combination of ACE inhibitor, diuretics, and calcium antagonist for the triple therapy in a single Pill Combination (SPC) is an efficient regimen in hypertension management. It is recommended by the ESH 2018 guideline, which offers better efficacy and compliance to treatment. Aim To evaluate the efficacy of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled hypertension. Methods We searched PubMed, Scopus, Web of Science, and Cochrane CENTRAL for relevant clinical trials. We conducted the risk of bias assessment using Cochrane's risk of bias tool. We performed the analysis of continuous data using mean difference (MD) and relative 95% confidence interval (CI), while dichotomous data were analyzed using risk ratio (RR) and relative 95% CI. We included the analysis of the following outcomes: systolic blood pressure (SBP), Diastolic blood pressure (DBP), Heart rate (HR), 24 h Ambulatory blood pressure monitoring (ABPM) for SBP, and 24 h ABPM for DBP. Results We included six clinical trials. We found that the triple therapy significantly reduces SBP by 24 mmHg (MD = - 24.65 [22.41, 26.89], (P < 0.01)), DBP by 12 mmHg (MD = 12.41 [11.53, 13.29], (P < 0.01)), 24-h ABPM for SBP by 14 mmHg (MD = 14.08 [9.10, 19.05], (P < 0.01)), and ABPM 24 h DBP by 7 mmHg (MD = 7.01 [5.37, 8.65], (P < 0.01)). We noted no significant difference of the single pill on heart rate (MD = 0.81 [- 0.04, 1.67], (P = 0.06). Conclusion perindopril/indapamide/amlodipine is effective in reducing systolic and diastolic blood pressures by 24 and 12 mmHg respectively. Over 24 h, the combination reduced systolic and diastolic blood pressures by 14 and 7 mmHg respectively.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 50 条
  • [1] Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis
    Shady Habboush
    Ahmed Adel Sofy
    Ahmed Taher Masoud
    Omar Cherfaoui
    Abdullah Mohamed Farhat
    Ahmed Taha Abdelsattar
    Ahmed Elmoursi
    [J]. High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 245 - 252
  • [2] Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis
    Xie, Mengxin
    Tang, Tianjiao
    Liang, Hongsheng
    [J]. CLINICAL CARDIOLOGY, 2023, 46 (08) : 886 - 898
  • [3] Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension A Systematic Review and Meta-Analysis
    Parati, Gianfranco
    Kjeldsen, Sverre
    Coca, Antonio
    Cushman, William C.
    Wang, Jiguang
    [J]. HYPERTENSION, 2021, 77 (02) : 692 - 705
  • [4] Harms of antihypertensive therapy for hypertension: a systematic review and meta-analysis
    Albasri, Ali
    Hattle, Miriam
    Koshiaris, Constantinos
    Dunnigan, Anna
    Smith, Margaret
    Roberts, Nia
    Stevens, Richard
    Riley, Richard
    Hobbs, Richard
    McManus, Richard J.
    Sheppard, James P.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2020, 34
  • [5] CLINICAL EFFICACY AND SAFETY OF AMLODIPINE/BISOPROLOL/PERINDOPRIL SINGLE-PILL AND FREE COMBINATION THERAPY IN PATIENTS WITH UNCONTROLLED ESSENTIAL HYPERTENSION
    Konradi, Alexandra
    Hassan, Hasnaa
    Lefay, Didier
    Isachenko, Elena
    Jamois, Aude
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E303 - E303
  • [6] Effect of Combined Statin and Antihypertensive Therapy in Patients with Hypertension: A Systematic Review and Meta-Analysis
    Wang, Ying
    Jiang, Long
    Feng, Shu-Jun
    Tang, Xin-Ying
    Kuang, Ze-Min
    [J]. CARDIOLOGY, 2020, 145 (12) : 802 - 812
  • [7] TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saleh, C.
    Kim, L.
    Whalen-Browne, A.
    Chu, D.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S37 - S38
  • [8] Single-pill Combination Therapy of Azilsartan Medoxomil/Chlorthalidone for Treatment of Hypertension: A Systematic Review
    Kwon, Ami
    Kim, Gee-Hee
    [J]. CLINICAL THERAPEUTICS, 2020, 42 (07) : 1390 - 1403
  • [9] Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis
    Kengne, Andre Pascal
    Briere, Jean-Baptiste
    Le Nouveau, Pauline
    Kodjamanova, Petya
    Atanasov, Petar
    Kochoedo, Maryse
    Irfan, Omar
    Khan, Zeba M.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (07) : 817 - 827
  • [10] SINGLE-PILL, TRIPLE ANTIHYPERTENSIVE THERAPY IN RURAL SUB-SAHARAN AFRICA: PRELIMINARY EXPERIENCE
    Muggli, Franco
    Parati, Gianfranco
    Hunjan, Isabella
    Stroppa, Clara
    Bianchetti, Mario
    Muvunyi, Bienvenu
    Ntaganda, Evariste
    Umulisa, Alice
    Sinabubaraga, Vincent
    Radovanovic, Dragana
    [J]. JOURNAL OF HYPERTENSION, 2024, 42